| |
GnRH agonist
|
Dienogest
|
P-value
|
|---|
|
Age (years)a
|
35.6 ± 3.5
|
36.1 ± 2.7
|
0.24
|
|
BMI (Kg/m2)a
|
22.5 ± 1.6
|
22.3 ± 1.9
|
0.18
|
|
Duration of subfertilitya
|
6.6 ± 1.5
|
7.2 ± 1.7
|
0.1
|
|
Previous ART (%) b
|
20/67 (29.85%)
|
17/67 (25.37%)
|
0.56
|
|
Previous live birth (%) b
|
10/67 (14.93%)
|
10/67 (14.93%)
|
1
|
|
Cause of infertility (%) b
|
|
Male
|
25 (37.31%)
|
27 (40.3%)
|
–
|
|
Anovulation
|
27 (40.3%)
|
30 (44.78%)
|
|
Tubal
|
32 (47.76%)
|
32 (47.76%)
|
|
uterine
|
23 (34.33%)
|
30 (44.78%)
|
|
Stage of Endometriosis b
|
|
Minimal
|
5/67 (7.46%)
|
8/67 (11.94%)
|
0.69
|
|
Mild
|
13/67 (19.4%)
|
12/67 (17.91%)
|
|
Moderate
|
27/67 (40.3%)
|
22/67 (32.84%)
|
|
Severe
|
22/67 (32.84%)
|
25/67 (37.31%)
|
|
FSH (IU/L)a
|
5.4 ± 1.7
|
4.3 ± 1.8
|
0.22
|
|
AMH (ng/ml)a
|
3.5 ± 1.3
|
2.8 ± 1.8
|
0.07
|
|
AFCa
|
12 ± 3.2
|
11.8 ± 2.3
|
0.08
|
- FSH Follicle-stimulating Hormone, AMH Anti-Mullerian Hormone, AFC Antral Follicle Count
- aValues are expressed as means ± standard deviations
- bValues expressed as percentages
